中华神经医学杂志
中華神經醫學雜誌
중화신경의학잡지
CHINESE JOURNAL OF NEUROMEDICINE
2012年
7期
734-736
,共3页
王凡%向贤宏%杨华%刘健%出良钊%隋建美%杨明%彭岗
王凡%嚮賢宏%楊華%劉健%齣良釗%隋建美%楊明%彭崗
왕범%향현굉%양화%류건%출량쇠%수건미%양명%팽강
福爱乐医用胶%栓塞%中枢神经系统%血管畸形
福愛樂醫用膠%栓塞%中樞神經繫統%血管畸形
복애악의용효%전새%중추신경계통%혈관기형
FuAiLe medical adhesive%Embolization%Central nervous system%Arteriovenous malformation
目的 探讨福爱乐医用胶(主要成分为α-氰基丙烯酸正辛酯和α-氰基丙烯酸正丁酯)在颅内动静脉畸形(CAVM)血管内治疗中的临床疗效.方法 局麻下经股动脉穿刺插管,微导管超选择插管至颅内病变部位,用福爱乐医用胶栓塞治疗CAVM 15例.其中病灶直径大于6 cm者4例,3.~6 cm者7例,小于3 cm者4例.单支供血者3例,2支供血者5例,3支供血者7例.栓塞加手术切除3例,栓塞后行伽马刀治疗2例.结果 15例患者共行26次栓塞治疗,8例J获80%以上栓塞,其中5例完全栓塞;5例获50%~80%栓塞;2例栓塞小于50%.所有患者手术过程中均未发生严重粘管情况.结论 福爱乐医胶治疗CAVM安全有效,是较为理想的栓塞材料.
目的 探討福愛樂醫用膠(主要成分為α-氰基丙烯痠正辛酯和α-氰基丙烯痠正丁酯)在顱內動靜脈畸形(CAVM)血管內治療中的臨床療效.方法 跼痳下經股動脈穿刺插管,微導管超選擇插管至顱內病變部位,用福愛樂醫用膠栓塞治療CAVM 15例.其中病竈直徑大于6 cm者4例,3.~6 cm者7例,小于3 cm者4例.單支供血者3例,2支供血者5例,3支供血者7例.栓塞加手術切除3例,栓塞後行伽馬刀治療2例.結果 15例患者共行26次栓塞治療,8例J穫80%以上栓塞,其中5例完全栓塞;5例穫50%~80%栓塞;2例栓塞小于50%.所有患者手術過程中均未髮生嚴重粘管情況.結論 福愛樂醫膠治療CAVM安全有效,是較為理想的栓塞材料.
목적 탐토복애악의용효(주요성분위α-청기병희산정신지화α-청기병희산정정지)재로내동정맥기형(CAVM)혈관내치료중적림상료효.방법 국마하경고동맥천자삽관,미도관초선택삽관지로내병변부위,용복애악의용효전새치료CAVM 15례.기중병조직경대우6 cm자4례,3.~6 cm자7례,소우3 cm자4례.단지공혈자3례,2지공혈자5례,3지공혈자7례.전새가수술절제3례,전새후행가마도치료2례.결과 15례환자공행26차전새치료,8례J획80%이상전새,기중5례완전전새;5례획50%~80%전새;2례전새소우50%.소유환자수술과정중균미발생엄중점관정황.결론 복애악의효치료CAVM안전유효,시교위이상적전새재료.
[Objective]To study the clinical efficacy of embolization in treating cerebral arteriovenous malformations(AVMs) using a new liquid embolic agent,FuAiLe medical adhesive (FAL,main ingredients:α-octyl cyanoacrylate and α-butyl cyanoacrylate).[Methods]Femoral artery was catheterized under local anesthesia,and then superselective catheterization to intracranial lesions were obtained using marathon 1.3F microcatheter.Fifteen cerebral AVMs were embolized by FAL.The diameter of AVMs was larger than 6 cm in 4 cases,3-6 cm in 7 cases and smaller than 3 cm in 4 cases.Single blood supply was observed in 3 cases,2 blood supplies in 5 cases and 3 blood supplies in 7 cases.Surgical ablation was applied after embolization in 3 cases,and gamma knife treatment was applied after embolization in 2 cases,[Results] A total of 26-time embolization was obtained in 15 patients;more than 80% embolization was achieved in 8 cases,including 5 with complete embolization;and 50%-80% embolization was achieved in 5 cases;less than 50% embolization was achieved in only 2 cases.No serious complication associated with embolization was noted in all patients.[Conclusion] It is safe and effective for FAL to treat cerebral AVMs and FAL may be an ideal embolic agent.